111 Operating Income 2018-2024 | YI

111 operating income from 2018 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
111 Annual Operating Income
(Millions of US $)
2024 $0
2023 $-49
2022 $-54
2021 $-101
2020 $-73
2019 $-71
2018 $-58
2017 $-38
111 Quarterly Operating Income
(Millions of US $)
2024-12-31 $-1
2024-09-30 $0
2024-06-30 $0
2024-03-31 $1
2023-12-31 $-29
2023-09-30 $-11
2023-06-30 $-6
2023-03-31 $-3
2022-12-31 $-14
2022-09-30 $-11
2022-06-30 $-12
2022-03-31 $-16
2021-12-31 $-18
2021-09-30 $-27
2021-06-30 $-29
2021-03-31 $-26
2020-12-31 $-25
2020-09-30 $-18
2020-06-30 $-13
2020-03-31 $-16
2019-12-31 $-24
2019-09-30 $-17
2019-06-30 $-15
2019-03-31 $-16
2018-09-30 $-19
2018-06-30
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.064B $1.973B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.946B 59.99
Hims & Hers Health (HIMS) United States $12.884B 133.86
Tempus AI (TEM) United States $12.253B 0.00
IRhythm Technologies (IRTC) United States $4.705B 0.00
Inspire Medical Systems (INSP) United States $3.914B 61.16
Privia Health (PRVA) United States $2.805B 191.75
Hinge Health (HNGE) United States $2.743B 0.00
Schrodinger (SDGR) United States $1.958B 0.00
Enovis (ENOV) United States $1.904B 10.62
Phreesia (PHR) United States $1.677B 0.00
Clover Health Investments (CLOV) United States $1.511B 0.00
Omnicell (OMCL) United States $1.424B 25.12
Azenta (AZTA) United States $1.410B 65.55
10x Genomics (TXG) United States $1.327B 0.00
Fulgent Genetics (FLGT) United States $0.661B 0.00
Claritev (CTEV) United States $0.646B 0.00
Butterfly Network (BFLY) United States $0.623B 0.00
Talkspace (TALK) United States $0.518B 154.75
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.410B 0.00
TruBridge (TBRG) United States $0.372B 824.67
Outset Medical (OM) United States $0.362B 0.00
Health Catalyst (HCAT) United States $0.276B 0.00
Nyxoah SA (NYXH) Belgium $0.264B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.200B 0.00
KORU Medical Systems (KRMD) United States $0.148B 0.00
Pulmonx (LUNG) United States $0.131B 0.00
EUDA Health Holdings (EUDA) Singapore $0.127B 0.00
American Well (AMWL) United States $0.112B 0.00
MDxHealth SA (MDXH) Belgium $0.099B 0.00
CareCloud (CCLD) United States $0.095B 3.61
HeartBeam (BEAT) United States $0.053B 0.00
P3 Health Partners (PIII) United States $0.046B 0.00
Zepp Health (ZEPP) Netherlands $0.036B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.027B 0.00
Zhongchao (ZCMD) China $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00